Leinonen E - Search Results

1

Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder.

Illi A, Setälä-Soikkeli E, Kampman O, Viikki M, Nuolivirta T, Poutanen O, Huhtala H, Mononen N, Lehtimäki T, Leinonen E. Illi A, et al. Among authors: leinonen e. Psychiatry Res. 2010 Mar 30;176(1):85-7. doi: 10.1016/j.psychres.2009.03.010. Epub 2010 Jan 13. Psychiatry Res. 2010. PMID: 20071037

2

Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire.

Kampman O, Lehtinen K, Lassila V, Leinonen E, Poutanen O, Koivisto A. Kampman O, et al. Among authors: leinonen e. Schizophr Res. 2000 Oct 27;45(3):223-34. doi: 10.1016/s0920-9964(99)00204-2. Schizophr Res. 2000. PMID: 11042440

3

Four-year outcome in non-compliant schizophrenia patients treated with or without home-based ambulatory outpatient care.

Kampman O, Illi A, Poutanen P, Leinonen E. Kampman O, et al. Among authors: leinonen e. Eur Psychiatry. 2003 Feb;18(1):1-5. doi: 10.1016/s0924-9338(02)00006-8. Eur Psychiatry. 2003. PMID: 12648888

4

Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics.

Illi A, Kampman O, Anttila S, Roivas M, Mattila KM, Lehtimäki T, Leinonen E. Illi A, et al. Among authors: leinonen e. Eur Neuropsychopharmacol. 2003 May;13(3):147-51. doi: 10.1016/s0924-977x(02)00176-1. Eur Neuropsychopharmacol. 2003. PMID: 12729939 Clinical Trial.

5

NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophrenia.

Anttila S, Kampman O, Illi A, Roivas M, Mattila KM, Lassila V, Lehtimäki T, Leinonen E. Anttila S, et al. Among authors: leinonen e. Psychiatr Genet. 2003 Jun;13(2):61-4. doi: 10.1097/01.ypg.0000056681.82896.6b. Psychiatr Genet. 2003. PMID: 12782960

6

Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia.

Illi A, Mattila KM, Kampman O, Anttila S, Roivas M, Lehtimäki T, Leinonen E. Illi A, et al. Among authors: leinonen e. J Clin Psychopharmacol. 2003 Oct;23(5):429-34. doi: 10.1097/01.jcp.0000088916.02635.33. J Clin Psychopharmacol. 2003. PMID: 14520117

7

Dopamine receptor D2 -141C Insertion/Deletion polymorphism in a Finnish population with schizophrenia.

Kampman O, Anttila S, Illi A, Lehtimäki T, Mattila KM, Roivas M, Leinonen E. Kampman O, et al. Among authors: leinonen e. Psychiatry Res. 2003 Nov 1;121(1):89-92. doi: 10.1016/s0165-1781(03)00201-4. Psychiatry Res. 2003. PMID: 14572625

8

Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics.

Anttila S, Illi A, Kampman O, Mattila KM, Lehtimäki T, Leinonen E. Anttila S, et al. Among authors: leinonen e. Pharmacogenetics. 2004 May;14(5):303-7. doi: 10.1097/00008571-200405000-00005. Pharmacogenetics. 2004. PMID: 15115916

9

Patient characteristics and diagnostic discrepancy in first-episode psychosis.

Kampman O, Kiviniemi P, Koivisto E, Väänänen J, Kilkku N, Leinonen E, Lehtinen K. Kampman O, et al. Among authors: leinonen e. Compr Psychiatry. 2004 May-Jun;45(3):213-8. doi: 10.1016/j.comppsych.2004.02.002. Compr Psychiatry. 2004. PMID: 15124152

10

Association of EGF polymorphism with schizophrenia in Finnish men.

Anttila S, Illi A, Kampman O, Mattila KM, Lehtimäki T, Leinonen E. Anttila S, et al. Among authors: leinonen e. Neuroreport. 2004 May 19;15(7):1215-8. doi: 10.1097/00001756-200405190-00027. Neuroreport. 2004. PMID: 15129177

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters